Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
35.15
-1.60 (-4.35%)
May 29, 2026, 3:00 PM CST

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
192.3246.61224.16362.07269.23254.37
Trading Asset Securities
2.62.617.5090200
Cash & Short-Term Investments
194.9249.21241.66362.07359.23454.37
Cash Growth
-8.96%3.12%-33.26%0.79%-20.94%298.63%
Accounts Receivable
709.2655.97570.35491.55491.69342.52
Other Receivables
2.182.5811.13.781.1
Receivables
711.37658.55571.35492.65495.48343.62
Inventory
66.4662.3885.6872.1278.5274.5
Prepaid Expenses
-1.05-000.06
Other Current Assets
26.0325.149.454.352.662.42
Total Current Assets
998.76996.33908.14931.19935.89874.98
Property, Plant & Equipment
620.79630.67572.3425.87378.35259.27
Other Intangible Assets
16.5616.916.3316.8217.5113.78
Long-Term Deferred Tax Assets
24.9124.9118.2114.079.567.11
Long-Term Deferred Charges
358.69354.04291.5195.76132.3134.93
Other Long-Term Assets
0.220.220.5628.895.2421.82
Total Assets
2,0202,0231,8071,6131,4791,212
Accounts Payable
141.3153.0786.2940.0680.6834.28
Accrued Expenses
0.2465.14368.06346.13321.65251.98
Short-Term Debt
303024.224.28535
Current Portion of Long-Term Debt
105.0668.8287.4231.6910-
Current Portion of Leases
-3.24----
Current Income Taxes Payable
14.7-9.443.749.464.03
Current Unearned Revenue
0.940.990.513.626.717.5
Other Current Liabilities
444.8515.8319.6726.7911.738.88
Total Current Liabilities
737.06737.07595.59476.22525.23341.66
Long-Term Debt
296.32323.72249.53177.2929.99-
Long-Term Leases
3.567.260.644.439.043.25
Long-Term Unearned Revenue
28.9529.1624.7919.9820.1118.67
Long-Term Deferred Tax Liabilities
8.398.392.462.722.562.3
Other Long-Term Liabilities
14.4613.480.531.210.091.33
Total Liabilities
1,0891,119873.54681.84587.02367.22
Common Stock
405.71405.71405.93406.16405.27405.27
Additional Paid-In Capital
560.58560.58606605.75580.95570.56
Retained Earnings
-32.25-59.44-81.7-87.04-104.59-131.17
Treasury Stock
-3.17-3.17-5.56-7.96--
Total Common Equity
930.87903.68924.68916.91881.63844.66
Minority Interest
0.310.38.8213.8610.22-
Shareholders' Equity
931.18903.98933.5930.77891.85844.66
Total Liabilities & Equity
2,0202,0231,8071,6131,4791,212
Total Debt
434.93433.03361.79237.61134.0338.25
Net Cash (Debt)
-240.04-183.82-120.13124.47225.2416.11
Net Cash Growth
----44.73%-45.88%381.08%
Net Cash Per Share
-0.59-0.45-0.300.310.561.08
Filing Date Shares Outstanding
405.21405.71405.93406.16405.27405.27
Total Common Shares Outstanding
405.21405.71405.93406.16405.27405.27
Working Capital
261.69259.26312.55454.97410.67533.31
Book Value Per Share
2.302.232.282.262.182.08
Tangible Book Value
914.31886.78908.35900.08864.11830.88
Tangible Book Value Per Share
2.262.192.242.222.132.05
Buildings
-224.69224.6996.22103.17103.17
Machinery
-383.4318.26299.39261.88245.29
Construction In Progress
-226.26211.27181.35135.4911.63